The bone growth stimulator market size has grown rapidly in recent years. It will grow from $1.8 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing incidence of bone fractures, rising spinal fusion procedures, expansion of orthopedic treatment centers, growing adoption of non-surgical bone healing methods, availability of external stimulation devices.
The bone growth stimulator market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for home-based orthopedic therapies, rising adoption of smart medical devices, expansion of outpatient orthopedic care, growing focus on reducing surgical interventions, technological advancements in bioelectrical stimulation. Major trends in the forecast period include increasing adoption of non-invasive bone growth stimulators, rising use of ultrasound-based stimulation devices, growing integration of smart monitoring features, expansion of home-use bone healing solutions, enhanced focus on faster fracture recovery.
The bone growth stimulators market is expected to experience significant growth, primarily driven by the increasing number of bone fractures. Factors such as age, dietary habits, and chronic disorders can weaken bones, making them more susceptible to fractures. Overuse or repetitive motions can also contribute to bone fractures. For instance, in June 2025, according to PubMed, U.S.-based National Institutes of Health reported that, in China projected data suggests that the ASIR for radius and/or ulna fractures in males will rise from 369 per 100,000 to 374 per 100,000 from 2022 to 2029. Further, the rate in females is expected to steadily increase from 427 per 100,000 in 2022 to 502 per 100,000 in 2036. Furthermore, it is projected that the number of osteoporotic fractures will increase by 68% annually from 2018 to 2040, reaching 3.2 million. The rising incidence of bone fractures is expected to be a significant driver for the growth of the bone growth stimulator market.
Major players in the bone growth stimulator market are advancing technologies such as low-intensity pulsed ultrasound (LIPUS) devices to support non-invasive fracture healing, enhance patient compliance, and reduce recovery time. LIPUS devices stimulate osteoblast activity at the fracture site, promoting faster bone regeneration compared to traditional electrical or implantable stimulators. In July 2025, Enovis Corporation launched the Manafuse Bone Growth Stimulator, a lightweight, portable device delivering daily 20-minute LIPUS therapy with built-in compliance tracking. The system enables up to 38% faster healing in acute fractures while improving usability and patient adherence compared to prior bulky or implant-based solutions.
In June 2025, Avista Healthcare Partners, a US-based private equity firm, acquired EBI, LLC for an undisclosed sum. Through this acquisition, Avista seeks to enhance its position in the bone growth stimulator market by leveraging EBI’s range of implantable and non-invasive bone growth stimulation devices for fracture healing and spinal fusion. EBI, LLC is a US-based medical technology company offering both implantable and non-invasive bone growth stimulation solutions, including OsteoGen, OrthoPak, and SpinalPak.
Major companies operating in the bone growth stimulator market are Bioventus LLC, Orthofix Medical Inc., Zimmer Biomet Holdings Inc., Medtronic plc, Enovis Inc., ZimVie Inc., DJO Global Inc., Smith & Nephew plc, Stryker Corporation, DePuy Synthes Inc., Globus Medical Inc., NuVasive Inc., Exactech Inc., Wright Medical Group N.V., RTI Surgical Holdings Inc., Ossatec Benelux BV, BTT Health GmbH, Stimulate Health Inc., Arthrex Inc., ConMed Corporation, Integra LifeSciences Corporation, OrthoPediatrics Corp.
North America was the largest region in the bone growth stimulator market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone growth stimulator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bone growth stimulator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the bone growth stimulator market by increasing costs of imported electronic components, sensors, power modules, and specialized medical-grade materials used in stimulation devices. Orthopedic hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher manufacturing costs for exports. These tariffs are raising device prices and slowing adoption. However, they are also encouraging domestic device manufacturing, local component sourcing, and innovation in cost-efficient bone healing technologies.
The bone growth stimulator market research report is one of a series of new reports that provides bone growth stimulator market statistics, including bone growth stimulator industry global market size, regional shares, competitors with a bone growth stimulator market share, detailed bone growth stimulator market segments, market trends and opportunities, and any further data you may need to thrive in the bone growth stimulator industry. This bone growth stimulator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A bone growth stimulator (BGS) is a device designed to enhance the natural fusion of bones following a fracture. The primary goal of BGS is to deliver increased energy to the healing bone surface, achieved through either pulsed electromagnetic or ultrasound methods. In the case of pulsed electromagnetic fields, the BGS attracts the oppositely charged ends of the bones, stimulating new bone growth and fusion, ultimately promoting the healing process. Bone growth stimulators are employed to aid in bone healing for challenging fractures or fusions by applying ultrasonic or electrical current to the fracture or fusion site.
The main types of bone growth stimulators (BGS) include bone growth stimulation devices, bone morphogenetic proteins (BMP), and platelet-rich plasma (PRP) therapy. Bone growth stimulation devices can be either implanted internally or worn externally using straps to secure them in place, enhancing the rate and shortening the time required for fracture healing. These devices find application in the treatment of fractures, spinal fusion, osteogenesis, arthrodesis treatment, and spondylolisthesis. The primary end-use sectors for BGS include hospitals and ambulatory surgical centers (ASCs), specialty clinics, and home care.
The bone growth stimulator market consists of sales of electrical and ultrasound bone growth stimulator. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The bone growth stimulator market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing demand for home-based orthopedic therapies, rising adoption of smart medical devices, expansion of outpatient orthopedic care, growing focus on reducing surgical interventions, technological advancements in bioelectrical stimulation. Major trends in the forecast period include increasing adoption of non-invasive bone growth stimulators, rising use of ultrasound-based stimulation devices, growing integration of smart monitoring features, expansion of home-use bone healing solutions, enhanced focus on faster fracture recovery.
The bone growth stimulators market is expected to experience significant growth, primarily driven by the increasing number of bone fractures. Factors such as age, dietary habits, and chronic disorders can weaken bones, making them more susceptible to fractures. Overuse or repetitive motions can also contribute to bone fractures. For instance, in June 2025, according to PubMed, U.S.-based National Institutes of Health reported that, in China projected data suggests that the ASIR for radius and/or ulna fractures in males will rise from 369 per 100,000 to 374 per 100,000 from 2022 to 2029. Further, the rate in females is expected to steadily increase from 427 per 100,000 in 2022 to 502 per 100,000 in 2036. Furthermore, it is projected that the number of osteoporotic fractures will increase by 68% annually from 2018 to 2040, reaching 3.2 million. The rising incidence of bone fractures is expected to be a significant driver for the growth of the bone growth stimulator market.
Major players in the bone growth stimulator market are advancing technologies such as low-intensity pulsed ultrasound (LIPUS) devices to support non-invasive fracture healing, enhance patient compliance, and reduce recovery time. LIPUS devices stimulate osteoblast activity at the fracture site, promoting faster bone regeneration compared to traditional electrical or implantable stimulators. In July 2025, Enovis Corporation launched the Manafuse Bone Growth Stimulator, a lightweight, portable device delivering daily 20-minute LIPUS therapy with built-in compliance tracking. The system enables up to 38% faster healing in acute fractures while improving usability and patient adherence compared to prior bulky or implant-based solutions.
In June 2025, Avista Healthcare Partners, a US-based private equity firm, acquired EBI, LLC for an undisclosed sum. Through this acquisition, Avista seeks to enhance its position in the bone growth stimulator market by leveraging EBI’s range of implantable and non-invasive bone growth stimulation devices for fracture healing and spinal fusion. EBI, LLC is a US-based medical technology company offering both implantable and non-invasive bone growth stimulation solutions, including OsteoGen, OrthoPak, and SpinalPak.
Major companies operating in the bone growth stimulator market are Bioventus LLC, Orthofix Medical Inc., Zimmer Biomet Holdings Inc., Medtronic plc, Enovis Inc., ZimVie Inc., DJO Global Inc., Smith & Nephew plc, Stryker Corporation, DePuy Synthes Inc., Globus Medical Inc., NuVasive Inc., Exactech Inc., Wright Medical Group N.V., RTI Surgical Holdings Inc., Ossatec Benelux BV, BTT Health GmbH, Stimulate Health Inc., Arthrex Inc., ConMed Corporation, Integra LifeSciences Corporation, OrthoPediatrics Corp.
North America was the largest region in the bone growth stimulator market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone growth stimulator market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bone growth stimulator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the bone growth stimulator market by increasing costs of imported electronic components, sensors, power modules, and specialized medical-grade materials used in stimulation devices. Orthopedic hospitals and specialty clinics in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher manufacturing costs for exports. These tariffs are raising device prices and slowing adoption. However, they are also encouraging domestic device manufacturing, local component sourcing, and innovation in cost-efficient bone healing technologies.
The bone growth stimulator market research report is one of a series of new reports that provides bone growth stimulator market statistics, including bone growth stimulator industry global market size, regional shares, competitors with a bone growth stimulator market share, detailed bone growth stimulator market segments, market trends and opportunities, and any further data you may need to thrive in the bone growth stimulator industry. This bone growth stimulator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A bone growth stimulator (BGS) is a device designed to enhance the natural fusion of bones following a fracture. The primary goal of BGS is to deliver increased energy to the healing bone surface, achieved through either pulsed electromagnetic or ultrasound methods. In the case of pulsed electromagnetic fields, the BGS attracts the oppositely charged ends of the bones, stimulating new bone growth and fusion, ultimately promoting the healing process. Bone growth stimulators are employed to aid in bone healing for challenging fractures or fusions by applying ultrasonic or electrical current to the fracture or fusion site.
The main types of bone growth stimulators (BGS) include bone growth stimulation devices, bone morphogenetic proteins (BMP), and platelet-rich plasma (PRP) therapy. Bone growth stimulation devices can be either implanted internally or worn externally using straps to secure them in place, enhancing the rate and shortening the time required for fracture healing. These devices find application in the treatment of fractures, spinal fusion, osteogenesis, arthrodesis treatment, and spondylolisthesis. The primary end-use sectors for BGS include hospitals and ambulatory surgical centers (ASCs), specialty clinics, and home care.
The bone growth stimulator market consists of sales of electrical and ultrasound bone growth stimulator. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Bone Growth Stimulator Market Characteristics
3. Bone Growth Stimulator Market Supply Chain Analysis
4. Global Bone Growth Stimulator Market Trends and Strategies
5. Bone Growth Stimulator Market Analysis of End Use Industries
7. Global Bone Growth Stimulator Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Bone Growth Stimulator Total Addressable Market (TAM) Analysis for the Market
9. Bone Growth Stimulator Market Segmentation
10. Bone Growth Stimulator Market Regional and Country Analysis
11. Asia-Pacific Bone Growth Stimulator Market
12. China Bone Growth Stimulator Market
13. India Bone Growth Stimulator Market
14. Japan Bone Growth Stimulator Market
15. Australia Bone Growth Stimulator Market
16. Indonesia Bone Growth Stimulator Market
17. South Korea Bone Growth Stimulator Market
18. Taiwan Bone Growth Stimulator Market
19. South East Asia Bone Growth Stimulator Market
20. Western Europe Bone Growth Stimulator Market
21. UK Bone Growth Stimulator Market
22. Germany Bone Growth Stimulator Market
23. France Bone Growth Stimulator Market
24. Italy Bone Growth Stimulator Market
25. Spain Bone Growth Stimulator Market
26. Eastern Europe Bone Growth Stimulator Market
27. Russia Bone Growth Stimulator Market
28. North America Bone Growth Stimulator Market
29. USA Bone Growth Stimulator Market
30. Canada Bone Growth Stimulator Market
31. South America Bone Growth Stimulator Market
32. Brazil Bone Growth Stimulator Market
33. Middle East Bone Growth Stimulator Market
34. Africa Bone Growth Stimulator Market
36. Bone Growth Stimulator Market Competitive Landscape and Company Profiles
37. Bone Growth Stimulator Market Other Major and Innovative Companies
40. Bone Growth Stimulator Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Bone Growth Stimulator Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses bone growth stimulator market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bone growth stimulator? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bone growth stimulator market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Electrical Bone Growth Stimulators; Ultrasound Bone Growth Stimulators; Pulsed Electromagnetic Field (PEMF) Bone Growth Stimulators2) By Application: Fractures; Spinal Fusion; Osteogenesis; Arthrodesis Treatment
3) By End User: Hospitals & ASCs; Specialty Clinics; Home Care
Subsegments:
1) By Electrical Bone Growth Stimulators: Implantable Electrical Bone Growth Stimulators; Non-Invasive (External) Electrical Bone Growth Stimulators; Direct Current (DC) Bone Growth Stimulators; Capacitive Coupling Bone Growth Stimulators2) By Ultrasound Bone Growth Stimulators: Low-Intensity Pulsed Ultrasound (LIPUS) Bone Growth Stimulators; External Ultrasound Bone Growth Stimulators; Portable Or Wearable Ultrasound Bone Growth Stimulators
3) By Pulsed Electromagnetic Field (PEMF) Bone Growth Stimulators: Non-Invasive PEMF Bone Growth Stimulators; Implantable PEMF Bone Growth Stimulators; Portable PEMF Bone Growth Stimulators; Wearable PEMF Bone Growth Stimulators
Companies Mentioned: Bioventus LLC; Orthofix Medical Inc.; Zimmer Biomet Holdings Inc.; Medtronic plc; Enovis Inc.; ZimVie Inc.; DJO Global Inc.; Smith & Nephew plc; Stryker Corporation; DePuy Synthes Inc.; Globus Medical Inc.; NuVasive Inc.; Exactech Inc.; Wright Medical Group N.V.; RTI Surgical Holdings Inc.; Ossatec Benelux BV; BTT Health GmbH; Stimulate Health Inc.; Arthrex Inc.; ConMed Corporation; Integra LifeSciences Corporation; OrthoPediatrics Corp.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Bone Growth Stimulator market report include:- Bioventus LLC
- Orthofix Medical Inc.
- Zimmer Biomet Holdings Inc.
- Medtronic plc
- Enovis Inc.
- ZimVie Inc.
- DJO Global Inc.
- Smith & Nephew plc
- Stryker Corporation
- DePuy Synthes Inc.
- Globus Medical Inc.
- NuVasive Inc.
- Exactech Inc.
- Wright Medical Group N.V.
- RTI Surgical Holdings Inc.
- Ossatec Benelux BV
- BTT Health GmbH
- Stimulate Health Inc.
- Arthrex Inc.
- ConMed Corporation
- Integra LifeSciences Corporation
- OrthoPediatrics Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.99 Billion |
| Forecasted Market Value ( USD | $ 2.89 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
